{"result": {"id": "chatcmpl-600", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Lung Cancer Research Community\",\n    \"summary\": \"This community focuses on lung cancer research, exploring its biological mechanisms, treatment strategies, and impact on patients. It encompasses entities like researchers, clinicians, pharmaceutical companies, and patient advocacy groups who collaborate to advance knowledge and improve care for those affected by the disease. The community's focus is driven by a shared goal of understanding and combating lung cancer through innovative approaches.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The Lung Cancer Research Community exhibits high impact due to its significant role in advancing scientific knowledge and developing new treatments for this prevalent disease. The community's diverse stakeholders contribute to a collective effort that directly impacts patient lives.\",\n    \"findings\": [\n        {\n            \"summary\": \"Lung cancer research is driven by a multidisciplinary approach, integrating insights from various fields like oncology, immunology, and genetics.\",\n            \"explanation\": \"The Lung Cancer Research Community fosters collaboration between researchers with expertise in diverse disciplines. This interdisciplinary approach allows for a comprehensive understanding of the disease's complexities, leading to more effective treatments and preventative measures. For example, oncologists focus on cancer treatment, while immunologists study the immune system's role in fighting cancer. Genetic studies help identify specific mutations that contribute to lung cancer development. This multidisciplinary collaboration is crucial for developing targeted therapies and personalized medicine approaches.\"\n        },\n        {\n            \"summary\": \"Clinical trials play a vital role in translating research findings into real-world patient care.\",\n            \"explanation\": \"Clinical trials are essential for testing the efficacy and safety of new treatments. They provide valuable data on how these treatments perform in diverse populations, allowing researchers to refine their approaches and develop more effective therapies. The Lung Cancer Research Community actively participates in clinical trials, ensuring that patients have access to the latest advancements in treatment options.\"\n        },\n        {\n            \"summary\": \"The community emphasizes patient-centered research, focusing on improving quality of life and addressing unmet needs.\",\n            \"explanation\": \"Patient-centric research aims to understand the impact of lung cancer on individuals' lives. This includes exploring the psychological, social, and economic consequences of the disease. The Lung Cancer Research Community actively engages with patients through support groups, patient registries, and clinical trials that prioritize their well-being. By incorporating patient perspectives into research design and implementation, the community strives to develop more holistic and effective treatment strategies.\"\n        },\n        {\n            \"summary\": \"The community is actively involved in developing innovative technologies for early detection and personalized medicine.\",\n            \"explanation\": \"Early detection of lung cancer through advanced imaging techniques like CT scans and PET scans is crucial for improving patient outcomes. The Lung Cancer Research Community invests in research to develop more sensitive and accurate diagnostic tools, enabling earlier intervention and potentially preventing the disease from progressing. Additionally, the community explores the potential of personalized medicine approaches based on individual genetic profiles, leading to tailored treatment strategies that maximize effectiveness.\"\n        },\n        {\n            \"summary\": \"The Lung Cancer Research Community is a vital force in advocating for increased funding and resources for research and patient care.\",\n            \"explanation\": \"Funding plays a crucial role in supporting research initiatives. The community actively engages with policymakers, foundations, and philanthropic organizations to secure financial support for lung cancer research. This advocacy ensures that the necessary resources are allocated to advance scientific knowledge and develop new treatments. Additionally, the community raises awareness about the importance of funding for lung cancer research, highlighting its impact on patients and society.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743346390, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 740, "prompt_tokens": 2048, "total_tokens": 2788, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n465,EXOSOMES,\"Exosomes are tiny vesicles released by cells, often containing proteins and RNA. They are a type of extracellular vesicle and can be extracted from cells such as MDA-MB-231 cells. Exosomes are involved in the spread of cancer cells and act as carriers for molecules like miRNAs.  They can also be used for drug delivery due to their ability to carry molecules like miR-502-5p.  Exosomes are a specific type of extracellular vesicle, and they play a role in the tumour microenvironment. \n\",10\n2228,VASCULOGENIC MIMICRY,\"VASCULOGENIC MIMICRY is a phenomenon in cancer research that describes the ability of tumor cells to create new blood vessels (angiogenesis) within a 3D channel architecture. This process allows for the growth of tumors without relying on existing blood vessel networks, essentially mimicking the formation of blood vessels in normal development.  Tumor cells can directly generate these new blood vessels through various mechanisms, contributing to their uncontrolled growth and spread. \n\",6\n4320,M<SUP>6</SUP>A MODIFICATION,Process being studied in breast cancer,4\n969,IMMUNE SYSTEM,Immune system affected by CD93,5\n667,TAXRU-NPS,\"The **TAXRU-NPS** is a type of drug used as a treatment for cancer. \n\",6\n672,LUNG CANCER,Type of cancer that TaxRu-NPs treat,9\n4321,TUMOR VASCULOGENIC MIMICRY,Process of creating new blood vessels by tumor cells,2\n464,EXTRACELLULAR VESICLES,\"**Extracellular vesicles (EVs)** are small, membrane-bound particles that play a crucial role in various biological processes.  They act as messengers, transferring molecules between cells and contributing to tumor growth. These vesicles, often referred to as **small extracellular vesicles**, contain a diverse range of cargo including proteins, lipids, and nucleic acids. \n\",4\n3539,FHL2,\"The **FHL2** gene, also known as Four and a half LIM domain protein-2, is a gene that plays a role in cancer metastasis.  It belongs to the family of four and a half LIM domain proteins, which are involved in various cellular processes including cell signaling and cytoskeletal organization. \n\",4\n2478,ASIS,A specific location or region is not mentioned in the text,3\n674,P53-MEDIATED APOPTOSIS,,2\n2719,HUCMSCS,Human umbilical cord mesenchymal stem cells,1\n2720,HYPOXIA-CONDITIONED HUCMSCS,,1\n3518,LYMPHANGIOGENESIS,\"Lymphangiogenesis is the formation of lymphatic vessels. This process involves the growth and development of new lymphatic vessels, which play a crucial role in the body's immune system by transporting lymph fluid and filtering waste products.  It can occur in various locations, including the cornea where it contributes to lymphatic drainage. The process of lymphangiogenesis is also closely linked to the formation of new lymphatic vessels, making it a key component of lymphatic vessel development. \n\",1\n5439,DISEASES,,1\n5440,IMMUNOGENICITY,,1\n5441,STABILITY,,1\n5442,TARGETING,,1\n462,BLOOD VESSELS,\"**Blood vessels** are a network of tubes that carry blood throughout the body.  They are essential for the growth and metastasis of malignant solid tumors, playing a role in tumor growth. Blood vessels transport blood throughout the body, acting as pathways for blood flow. These structures are formed by endothelial cells and can be affected by implantation procedures. They are also involved in the transportation of oxygen and nutrients to various tissues.  Blood vessels are essential for the body's circulatory system. \n\",5\n463,TUMOR CELL,\"**Tumour cells** are involved in the growth of **Lymphoma**, and they play a role in the development of **cancer**. \n\",4\n428,METASTASIS,\"**Metastasis** is a type of cancer spread, where cancerous cells break away from their original site and travel to other parts of the body. This process, known as **spread of cancer cells**, can be a major cause of mortality in various cancers, including breast cancer.  Metastasis is often linked to **tumor growth** and **angiogenesis**, which are processes that allow for the development and spread of tumors. \n\",6\n862,MELITTIN,Melittin is a peptide that inhibits metastasis,3\n3555,SCLC,\"**Small cell lung cancer (SCLC)** is a specific type of lung cancer. \n\",4\n3557,VASCULOGENESIS,,4\n466,BC CELLS,Cells involved in cancer,3\n671,CASPASE-3,Caspase-3 is a protein involved in apoptosis,1\n673,VEGF/Β-CATENIN PATHWAY,,1\n3720,MALIGNANT SOLID TUMORS,A type of cancer that grows in the body,2\n3651,IL10,Anti-inflammatory marker,6\n3765,MESODERM,\"The **mesoderm** is a fundamental tissue that serves as the foundation for various organs and systems within an organism. It plays a crucial role in forming the body's skeletal structure and other essential components.  Furthermore, research on mesoderm has focused on understanding the function of interleukin-10 (IL10) within this tissue type. \n\",1\n3768,BLOOD VESSEL ORGANOID,\"The **blood vessel organoid** is a 3D model created using human induced pluripotent stem cells (hiPSCs). This model allows researchers to study the effects of IL-10 on blood vessel development.  It provides a detailed, three-dimensional structure of blood vessels for in vitro research. \n\",1\n3770,BLOOD FLOW PERFUSION RECOVERY,,1\n3771,MESODERM INDUCTION STAGE,,1\n4322,THERAPEUTIC TARGETS,Potential targets for future cancer treatments,1\n4329,ANTI-ANGIOGENIC DRUGS,Drugs used to inhibit angiogenesis,2\n2246,CAFF,Cancer-associated fibroblasts,2\n4675,ADVANCED LUNG CANCER,Type of lung cancer,1\n4676,STAGE III LUNG CANCER,Specific stage of advanced lung cancer,1\n2479,THERAPEUTIC RESISTANCE,,2\n2480,NEWLY IDENTIFIED REGULATORS,,2\n3546,LUNG ADENOCARCINOMAS,Type of cancer,1\n3556,TUMOUR IMMUNE MICROENVIRONMENT,The environment surrounding a tumor that influences its response to treatment,1\n1788,NATURAL KILLER CELLS,\"Natural killer (NK) cells are a type of immune cell that plays a crucial role in the body's defense against both cancer and infections. These cells can identify and destroy cancer cells by recognizing specific markers on their surface, as well as eliminate infected or abnormal cells.  \n\",1\n467,CLINICAL SETTING,,1\n864,MMPS,,1\n865,EMT MARKERS,,1\n3721,REAL-TIME MONITORING,The process of observing and tracking the development of vasculogenic mimicry in real time,2\n3722,CLINICAL APPLICATIONS,A field where vasculogenic mimicry is used to develop new treatments for cancer,2\n1476,LUNG ADENOCARCINOMA,A type of respiratory disease,1\n3724,NONINVASIVE OPTICAL DETECTION,A method of detecting vasculogenic mimicry using light,1\n4697,ANTI-ANGIOGENIC RESPONSE,A medical treatment used to fight cancer,2\n4698,IMMUNE-BASED PROGNOSTIC MODEL,A tool for predicting the outcome of a patient's treatment,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n182,EXOSOMES,ANGIOGENESIS,\"**Exosomes** are tiny vesicles released by cells that can be utilized to deliver drugs for **angiogenesis**, the process of new blood vessel formation.  These exosomes also play a significant role in **angiogenesis** itself, suggesting their involvement in various biological processes related to blood vessel development and growth. \n\",169\n957,VASCULOGENIC MIMICRY,ANGIOGENESIS,Both processes can feed cancer cells and allow for tumor growth,165\n1852,M<SUP>6</SUP>A MODIFICATION,ANGIOGENESIS,m<sup>6</sup>A modification influences angiogenesis and vasculogenic mimicry in breast cancer,163\n1637,IMMUNE SYSTEM,MACROPHAGES,The immune system regulates the early inflammatory phase of tissue repair,21\n253,TAXRU-NPS,LUNG CANCER,TaxRu- NPs are used to treat lung cancer,15\n1851,BREAST CANCER,TUMOR VASCULOGENIC MIMICRY,Tumor vasculogenic mimicry is a factor in breast cancer,15\n178,EXTRACELLULAR VESICLES,EXOSOMES,Exosomes are involved in the promotion of angiogenesis,14\n1557,FHL2,LUNG CANCER,FHL2 is expressed by CAFs and contributes to the progression of lung cancer,13\n1122,ASIS,LUNG CANCER,\"The paper reviews the impact of angiogenesis and EMT on lung cancer, which could be relevant to treatment\",12\n258,LUNG CANCER,P53-MEDIATED APOPTOSIS,Lung cancer cells are affected by p53-mediated apoptosis induced by TaxRu-NPs,11\n1233,HUCMSCS,EXOSOMES,hucMSCs produce exosomes that can enhance angiogenesis,11\n1234,EXOSOMES,HYPOXIA-CONDITIONED HUCMSCS,Hypoxia-conditioned hucMSCs produce exosomes that enhance angiogenesis,11\n2429,EXOSOMES,LYMPHANGIOGENESIS,Exosomes can be used to deliver drugs for lymphangiogenesis,11\n2430,EXOSOMES,DISEASES,Exosomes are a potential drug delivery system for various diseases and injuries,11\n2431,EXOSOMES,IMMUNOGENICITY,Exosomes exhibit minimal immunogenicity,11\n2432,EXOSOMES,STABILITY,Exosomes possess remarkable stability,11\n2433,EXOSOMES,TARGETING,Exosomes have inherent and adjustable targeting capabilities,11\n173,BLOOD VESSELS,TUMOR CELL,Blood vessels promote tumor cell expansion and metastasis,9\n371,METASTASIS,MELITTIN,\"Melittin inhibits the spread of CRC\nMelittin inhibits metastasis of CRC\",9\n175,TUMOR CELL,EXTRACELLULAR VESICLES,Extracellular vesicles are involved in tumor growth,8\n255,TAXRU-NPS,P53-MEDIATED APOPTOSIS,TaxRu-NPs activate p53 to induce apoptosis in cancer cells,8\n1567,SCLC,VASCULOGENESIS,VEGF expression is involved in the formation of new blood vessels,8\n179,BC CELLS,EXTRACELLULAR VESICLES,BC cells release exosomes to facilitate angiogenesis,7\n252,CASPASE-3,TAXRU-NPS,Caspase-3 is activated by TaxRu-NPs to induce apoptosis in cancer cells,7\n254,TAXRU-NPS,VEGF/Β-CATENIN PATHWAY,\"TaxRu-NPs decrease the VEGF/β-catenin pathway, which prevents angiogenesis and metastasis in lung cancer\",7\n1601,MALIGNANT SOLID TUMORS,BLOOD VESSELS,Tumors depend on blood vessels for growth and metastasis,7\n1613,IL10,MESODERM,IL10 knockdown in zebrafish larvae caused defective mesoderm formation,7\n1614,IL10,BLOOD VESSEL ORGANOID,IL10 promotes blood vessel organoid development,7\n1617,IL10,BLOOD FLOW PERFUSION RECOVERY,IL10 treatment during mesoderm induction stage enhances blood flow perfusion recovery,7\n1618,IL10,MESODERM INDUCTION STAGE,IL10 treatment during mesoderm induction stage enhances blood flow perfusion recovery and increases vasculogenesis and angiogenesis,7\n1856,VASCULOGENIC MIMICRY,THERAPEUTIC TARGETS,Vasculogenic mimicry is a potential target for new therapies in cancer treatment,7\n2000,ANTI-ANGIOGENIC DRUGS,IMMUNE SYSTEM,Anti-angiogenic drugs can be used to treat lung cancer by influencing the immune system,7\n1555,CAFF,FHL2,FHL2 is a component of focal adhesion structures in CAFs,6\n2001,ADVANCED LUNG CANCER,IMMUNE SYSTEM,Immune system plays a role in prognosis prediction of advanced lung cancer,6\n2002,STAGE III LUNG CANCER,IMMUNE SYSTEM,Specific stage of advanced lung cancer is related to immune system,6\n1123,ASIS,THERAPEUTIC RESISTANCE,\"The paper reviews the impact of angiogenesis and EMT on lung cancer, which could be relevant to treatment\",5\n1124,ASIS,NEWLY IDENTIFIED REGULATORS,\"The paper reviews the impact of angiogenesis and EMT on lung cancer, which could be relevant to treatment\",5\n1559,FHL2,LUNG ADENOCARCINOMAS,FHL2 knockout reduced metastasis in lung adenocarcinomas,5\n1565,SCLC,TUMOUR IMMUNE MICROENVIRONMENT,The tumor immune microenvironment plays an important role in facilitating immunotherapy resistance,5\n1566,SCLC,NATURAL KILLER CELLS,Poor infiltration of natural killer cells fosters a pro-metastatic environment in SCLC,5\n181,BC CELLS,CLINICAL SETTING,Understanding BC cell's role in angiogenesis is important for clinical settings,4\n372,MELITTIN,MMPS,Melittin suppresses the expression of MMPs,4\n373,MELITTIN,EMT MARKERS,Melittin regulates the expression of EMT markers,4\n1604,REAL-TIME MONITORING,CLINICAL APPLICATIONS,\"Clinical applications of vasculogenic mimicry are being developed\nReal-time monitoring is important for clinical applications of vasculogenic mimicry\",4\n1556,CAFF,LUNG ADENOCARCINOMA,CAFs contribute to the progression of lung adenocarcinoma,3\n1605,CLINICAL APPLICATIONS,NONINVASIVE OPTICAL DETECTION,Noninvasive optical detection can be used for clinical applications,3\n2013,ANTI-ANGIOGENIC RESPONSE,IMMUNE-BASED PROGNOSTIC MODEL,The immune-based prognostic model can predict the outcome of anti-angiogenic treatment in lung cancer patients,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_3bcfde2b915b62936f23c95485990ed29d405f5ad02d9155d5fd82d41b36a55b_v2"}